We scan new podcasts and send you the top 5 insights daily.
Fairfax targets well-run insurers that invest their float conservatively for low returns (e.g., 4%). By applying its superior investment arm to boost the float's return (e.g., to 7%), it dramatically increases the acquired company's ROE without altering core underwriting operations.
For its first two decades, Fairfax's insurance underwriting was unprofitable (combined ratio >100%). Through disciplined management, it now operates at a ~97% ratio, turning its insurance float from costly capital into free, profitable leverage—a critical business model inflection point.
Instead of just investing its insurance float, Apollo seeds origination platforms and raises outside capital. This structure applies fee-and-carry economics to the deals, effectively multiplying the return potential of its initial insurance capital.
Generating higher returns on the asset side of an insurer's balance sheet is not just about profit. It builds a 'fortress balance sheet,' which in turn allows the underwriting side to take on larger, more novel, and longer-tail risks that competitors cannot, creating a significant competitive advantage.
While a soft market slows premium growth, it also reduces the need for capital to back new business. This frees up significant cash flow for Fairfax to execute accretive buybacks and other capital returns, especially when the stock trades at a discount to its intrinsic value.
In a masterclass of capital allocation, Fairfax sold a 10% stake in its subsidiary, Odyssey, at a premium valuation (1.7x book). It then used the proceeds to repurchase its own parent company shares, which were trading at a discount (0.9x book), executing a perfect arbitrage.
Often called the "Berkshire of the North," Fairfax has mirrored Warren Buffett's model using insurance float, a decentralized structure, and shareholder-first culture. This strategy has resulted in an 18% compounded annual book value growth for nearly four decades.
The book "The Fairfax Way" reveals the company's early success wasn't merely from acquiring insurers at low valuations. The critical, often overlooked element was the immense time, money, and work required to revamp and stabilize these acquired operations to an acceptable level, a key lesson for value investors.
Fairfax maintains a balance sheet with roughly $75 billion in investments against $25 billion in equity. This leverage is primarily funded by low-cost insurance float and some debt, creating a powerful engine for returns that the speakers argue is a "better mousetrap than Berkshire."
Fairfax's investment arm, HWIC, charges its subsidiaries management fees. However, because Fairfax fully owns HWIC, these fees are captured by the parent company and net to zero. This structure aligns interests and prevents value leakage common in external management arrangements.
Fairfax's early strategy involved acquiring troubled insurers at deep discounts to book value. While economically sound (buying float for nearly free), this meant inheriting problematic reserve books that took years to fix, creating a lagging accounting narrative that they were poor underwriters.